Thierry Buclin

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Sylvain Goutelle

Université Claude Bernard Lyon 1

FRANCE

View details

Peter Burckhardt

Chief resident- then Head of Department- then Chief

Lausanne University Hospital

SWITZERLAND

View details

Nicolas Widmer

Lausanne University Hospital

SWITZERLAND

View details

Yann Thoma

Professor

School of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland

SWITZERLAND

View details

Kim Dao

SWITZERLAND

View details

Katharina Kusejko

University of Zurich

SWITZERLAND

View details

Dionysios Neofytos

University Hospital of Geneva

SWITZERLAND

View details

Aline Munting

Chief resident

Centre Hospitalier Universitaire Vaudois

SWITZERLAND

View details

Matthias Cavassini

SWITZERLAND

View details

Monia Guidi

SWITZERLAND

View details

Catia Marzolini

University Hospital Basel

SWITZERLAND

View details

Huldrych Günthard

Professor, MD

University Hospital of Zurich

SWITZERLAND

View details

Andrea O. Rossetti

SWITZERLAND

View details

Laurent Decosterd

Head of the Laboratory of Clinical Pharmacology / Associated Professor

Centre Hospitalier Universitaire Vaudois

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thierry Buclin

Research Interests

Explore related searches

Contact this professor

Articles (19)

Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model‐Informed Precision Dosing

Population pharmacokinetics of bictegravir in real-world people with HIV

Is the salivary concentration of lamotrigine and levetiracetam associated with clinical outcome?

Clinical value of saliva therapeutic drug monitoring of newer antiseizure medications.

N-of-1 tests in general practice: pharmacological considerations

Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures

Population Pharmacokinetics in Oncology and Its Clinical Applications

Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration

From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure

Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others.

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland

An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup

Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control

Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases

Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs

Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

Collaborators (14)

Sylvain Goutelle

Peter Burckhardt

Nicolas Widmer

Yann Thoma

Kim Dao

Katharina Kusejko

Dionysios Neofytos

Aline Munting

Matthias Cavassini

Monia Guidi

Catia Marzolini

Huldrych Günthard

Andrea O. Rossetti

Laurent Decosterd

Make your next move.